← Back to Clinical Trials
Recruiting NCT05289999

NCT05289999 Interest of the Virtual Reality as an Analgesic Support and in the Management the Pre-procedural Anxiety in Rheumatology

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05289999
Status Recruiting
Phase
Sponsor Centre Hospitalier le Mans
Condition Radiculopathy
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2022-06-10
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Virtual reality headset for first injectionVirtual reality headset for second injection

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2022-06-10 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

As a part of the current rheumatological practice skills, epidural injections through the sacrococcygeal hiatus take part in the strategy for managing radicular diseases. This technical act is easily performed in an outpatient context since it is a brief procedure, performed under clinical and ultrasound control, with good tolerance. Nevertheless, epidural injections by the way of the sacrococcygeal hiatus can be responsible of anxiety for the patient and meet the definition of pain induced by treatment. Among the non-pharmacological methods that can be offered to the patient in this context, hypnosis and distraction allow psycho-corporal support acting on certain factors influencing the painful experience of the gesture: duration of the gesture, calm and pleasant environment, etc... That is the context in which the use of virtual reality is of interest. Its use in supporting procedures generating induced pain has already been evaluated in several studies, in particular in the fields of surgery and anaesthesiology. The use of a virtual reality device also seems suitable in the context of epidural injections, but this theoretical and plausible interest remains to be demonstrated. To our knowledge, the literature on the use of a virtual reality headset to support invasive procedures in rheumatology remains poorly developed. The objective of this study is therefore to assess the interest of using a virtual reality headset in the support of pain relief and the management of peri-procedural anxiety when performing epidural injections through the sacrococcygeal hiatus.

Eligibility Criteria

Inclusion Criteria: * Adult patient (age ≥ 18 years) * Hospitalized in a day-hospitalization department at the General Hospital of Le Mans * For whom a diagnosis of radiculalgia with a duration of less than 6 months is made, for which the imaging is compatible with the symptoms according to the clinician's interpretation * For whom the indication of at least 2 epidural injections by the way of the sacrococcygeal hiatus is retained * Having never experienced an epidural injection through the sacrococcygeal hiatus * Patient able and willing to answer the auto-administered surveys * Person affiliated or beneficiary of a social security * Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research) after oral and written information Exclusion Criteria: * Patient with comorbidity of epilepsy * Patient with a contraindication to performing epidural injections through the sacrococcygeal hiatus * Patient suffering from blindness and / or deafness * Person with a known significant intolerance towards the use of screens and / or virtual reality devices * Patient receiving benzodiazepines and / or other sedative treatment * Patient with a known depressive disease followed by a psychiatrist * Pregnant, breastfeeding or parturient woman * Person deprived of liberty by judicial or administrative decision * Person under forced psychiatric care * Person subject to legal protection * Person unable to express consent * Patient who had participated in an interventional study during the last 30 days * Severely impaired physical and / or mental health which, according to the investigator, may affect the compliance of the study participant

Contact & Investigator

Central Contact

Christelle JADEAU

✉ cjadeau@ch-lemans.fr

📞 +33244710781

Frequently Asked Questions

Who can join the NCT05289999 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05289999 currently recruiting?

Yes, NCT05289999 is actively recruiting participants. Contact the research team at cjadeau@ch-lemans.fr for enrollment information.

Where is the NCT05289999 trial being conducted?

This trial is being conducted at Le Mans, France.

Who is sponsoring the NCT05289999 clinical trial?

NCT05289999 is sponsored by Centre Hospitalier le Mans. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology